Search Results - "Ribera, Pilar"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Phosphodiesterase 4 is overexpressed in keloid epidermal scars and its inhibition reduces keratinocyte fibrotic alterations by Milara, Javier, Ribera, Pilar, Marín, Severiano, Montero, Paula, Roger, Inés, Cortijo, Julio

    Published in Molecular medicine (Cambridge, Mass.) (02-09-2024)
    “…Epidermal remodeling and hypertrophy are hallmarks of skin fibrotic disorders, and keratinocyte to mesenchymal (EMT)-like transformations drive epidermis…”
    Get full text
    Journal Article
  2. 2

    N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro by Milara, Javier, Martínez-Expósito, Fernando, Montero, Paula, Roger, Inés, Bayarri, Maria Amparo, Ribera, Pilar, Oishi-Konari, Miriam Natsuki, Alba-García, Jose Ramón, Zapater, Enrique, Cortijo, Julio

    “…Inflammasome activation is one of the first steps in initiating innate immune responses. In this work, we studied the activation of inflammasomes in the…”
    Get full text
    Journal Article
  3. 3

    Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies by Peiró, Teresa, Alonso-Carpio, Miriam, Ribera, Pilar, Almudéver, Patricia, Roger, Inés, Montero, Paula, Marín, Severiano, Milara, Javier, Cortijo, Julio

    “…Skin fibrosis is a hallmark of a wide array of dermatological diseases which can greatly impact the patients' quality of life. Galectin-3 (GAL-3) has emerged…”
    Get full text
    Journal Article
  4. 4

    Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro by Roger, Inés, Montero, Paula, García, Antonio, Milara, Javier, Ribera, Pilar, Pérez-Fidalgo, Jose Alejandro, Cortijo, Julio

    Published in Pharmaceuticals (Basel, Switzerland) (01-09-2022)
    “…Delayed-type hypersensitivity (DTH) is caused by a broad number of drugs used in clinic, and antineoplastic drugs show an elevated proportion of DTH, which…”
    Get full text
    Journal Article
  5. 5

    MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease by Milara, Javier, Díaz-Platas, Lucía, Contreras, Sonia, Ribera, Pilar, Roger, Inés, Ballester, Beatriz, Montero, Paula, Cogolludo, Ángel, Morcillo, Esteban, Cortijo, Julio

    Published in Respiratory research (20-11-2018)
    “…Lung inflammation in COPD is poorly controlled by inhaled corticosteroids (ICS). Strategies to improve ICS efficacy or the search of biomarkers who may select…”
    Get full text
    Journal Article
  6. 6

    Phosphodiesterase 4 is overexpressed in human keloids and its inhibition reduces fibroblast activation and skin fibrosis by Milara, Javier, Ribera, Pilar, Marín, Severiano, Montero, Paula, Roger, Inés, Tenor, Herman, Cortijo, Julio

    Published in Chemico-biological interactions (01-10-2024)
    “…There is a pressing medical need for improved treatments in skin fibrosis including keloids and hypertrophic scars (HTS). This study aimed to characterize the…”
    Get full text
    Journal Article
  7. 7

    A preclinical model for skin sensitization prediction of antineoplasic drugs by Perez-Fidalgo, Jose Alejandro, Montero Magallo, Paula, Roger Laparra, Ines, Ribera Alba, Pilar, Poveda Ferriols, Jesus, Milara Paya, Javier, Cervantes, Andres, Cortijo Gimeno, Julio

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e15643 Background: Skin side effects are common manifestations of antineoplastic drugs that are frequently observed in early clinical trials…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Controlled building of CdSe@ZnS/Au and CdSe@ZnS/ Au2S/Au nanohybrids by Galian, Raquel E., Diaz, Pilar, Ribera, Antonio, Rincón-Bertolín, Alejandro, Agouram, Saïd, Pérez-Prieto, Julia

    Published in Nano research (01-07-2015)
    “…The addition of Au3. to spherical amine-capped CdSe@ZnS nanoparticles in toluene at room temperature and under darkness can lead to ternary CdSe@ZnS/Au…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Tratamiento de la hiperfosfatemia asociada a la enfermedad renal crónica con carbonato de lantano. Nuevas evidencias by González Casaús, María Luisa, González Parra, Emilio, Navas Serrano, Víctor Manuel, Gracia Iguacel, Carolina, de Ribera Pieras, Pilar, de Los Ríos, Jesús Egido

    Published in Diálisis y traspante (2011)
    “…Resumen La hiperfosfatemia asociada a la enfermedad renal crónica (ERC) está implicada en el desarrollo de calcificaciones vasculares y puede considerarse como…”
    Get full text
    Journal Article